Periodic Reporting for period 1 - PrevictDrugs (Smartphone Measured Eye-Based Digital Biomarkers for Drug Use Detection)
Période du rapport: 2019-09-01 au 2020-02-29
The overall objective of this project was to develop and optimize a business plan that will guide the development and commercialization of Kontigo Care’s Previct Drugs - a robust, app-based, eHealth-platform for continuous self-monitoring of drug use.
The feasibility study has confirmed a significant business opportunity within the global drug use monitoring market.
We strive to develop our prototype further and validate the potential for a medical device that will enable early therapeutic interventions, daily home-based therapeutic interventions and appropriate distribution of healthcare resources. Drug abuse is a serious global health problem and Kontigo Care is convinced its innovative approach will have a significant impact on the health-economic burden of drug abuse in Europe and worldwide.